Today: 7 February 2026
Subscribe
Browse Category

NYSE:STZ News 12 December 2025 - 21 January 2026

Constellation Brands (STZ) stock cools in premarket after Tuesday pop — what matters now

Constellation Brands (STZ) stock cools in premarket after Tuesday pop — what matters now

Constellation Brands shares fell 0.5% to $162.87 in premarket trading Wednesday after a 4.47% jump Tuesday, bucking a broader market selloff. The company faces pressure from weaker beer demand among Hispanic consumers, higher aluminum packaging costs, and a 3% drop in quarterly beer depletions. A $1.02 per share dividend will be paid Feb. 12 to holders of record Jan. 29.
21 January 2026
··
Constellation Brands stock dips in premarket after earnings beat — what investors watch on the call

Constellation Brands stock dips in premarket after earnings beat — what investors watch on the call

Constellation Brands shares fell 2.2% premarket to $140.49 after the company cut its full-year earnings outlook despite beating profit estimates. Net sales dropped 10% to $2.22 billion for the quarter ended Nov. 30. Beer shipments fell 2.2%, with Modelo Especial depletions down 4% and Corona Extra down nearly 9%. The board declared a $1.02 quarterly dividend, payable Feb. 12.
8 January 2026
··
Constellation Brands Stock (STZ) News Today: Why Shares Are Rebounding, What Wall Street Forecasts Next, and the Key Catalysts Into 2026 (Dec. 23, 2025)

Constellation Brands Stock (STZ) News Today: Why Shares Are Rebounding, What Wall Street Forecasts Next, and the Key Catalysts Into 2026 (Dec. 23, 2025)

Constellation Brands, Inc. (NYSE: STZ) is ending 2025 the way it spent much of the year: as one of the market’s most debated “defensive” stocks. On December 23, 2025, STZ was trading around $141.74, a level that reflects a sharp rebound from the mid-$130s area and puts the beer, wine, and spirits giant back in the spotlight for momentum traders and long-term investors alike. MarketWatch+1 The big question behind today’s move is the same one that’s been haunting the stock for months: Is Constellation Brands stock in a real turnaround—or just bouncing because it got too cheap and too hated?
23 December 2025
·
Constellation Brands (STZ) Stock Today: Latest News, Analyst Forecasts, and What Investors Are Watching on December 12, 2025

Constellation Brands (STZ) Stock Today: Latest News, Analyst Forecasts, and What Investors Are Watching on December 12, 2025

Published: December 12, 2025Constellation Brands, Inc. (NYSE: STZ ) — the US owner of the Corona and Modelo beer franchises — is back in focus for investors after a sharp 2025 drawdown, a recent two-day rebound, and a growing debate on what “normal” demand looks like for premium imported beer in a pressured consumer environment.MarketWatch+ 3Constellation Brands, Inc.+ 3DRY+ 3 As of early afternoon trading on Friday, Dec. 12 , STZ shares were around $148 , down roughly 0.8% from the prior close after opening near $150 . Below is a detailed roundup of today’s price action , the freshest
12 December 2025
·

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
COPENHAGEN, February 7, 2026, 23:19 CET — Market closed. Novo Nordisk A/S Class B shares will be back in focus when trading resumes on Monday after telehealth firm Hims & Hers said it would stop offering access to a $49 compounded version of Novo’s Wegovy pill following U.S. regulatory warnings. Novo’s Copenhagen-listed shares ended Friday at 295.50 crowns, up 5.3%, according to Reuters market data. (Reuters) Why it matters now: the $49 offer put a fresh spotlight on how quickly cheaper, unapproved copies can spread in the fast-growing obesity-drug market — and how hard it may be for drugmakers to
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop